[{"address1": "2450 Holcombe Boulevard", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "832 834 9144", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. David J. Arthur M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 726185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark J. Rosenblum CPA", "age": 71, "title": "Executive VP of Finance & CFO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 339050, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.35, "open": 1.35, "dayLow": 1.31, "dayHigh": 1.37, "regularMarketPreviousClose": 1.35, "regularMarketOpen": 1.35, "regularMarketDayLow": 1.31, "regularMarketDayHigh": 1.37, "payoutRatio": 0.0, "beta": 0.837, "forwardPE": -0.14503817, "volume": 38818, "regularMarketVolume": 38818, "averageVolume": 2196784, "averageVolume10days": 67580, "averageDailyVolume10Day": 67580, "bid": 1.26, "ask": 1.35, "bidSize": 1, "askSize": 1, "marketCap": 2106148, "fiftyTwoWeekLow": 1.22, "fiftyTwoWeekHigh": 7.2, "fiftyDayAverage": 1.9111, "twoHundredDayAverage": 2.153425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1009618, "profitMargins": 0.0, "floatShares": 1329194, "sharesOutstanding": 1583570, "sharesShort": 19341, "sharesShortPriorMonth": 31114, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.012200001, "heldPercentInsiders": 0.022909999, "heldPercentInstitutions": 0.05238, "shortRatio": 0.0, "shortPercentOfFloat": 0.0123000005, "impliedSharesOutstanding": 1583570, "bookValue": 2.029, "priceToBook": 0.65549535, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -4993640, "trailingEps": -5.14, "forwardEps": -9.17, "lastSplitFactor": "1:8", "lastSplitDate": 1718582400, "enterpriseToEbitda": 0.194, "52WeekChange": -0.70753896, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 1.33, "recommendationKey": "none", "totalCash": 3284029, "totalCashPerShare": 2.279, "ebitda": -5211881, "totalDebt": 328849, "quickRatio": 3.514, "currentRatio": 4.09, "debtToEquity": 11.244, "returnOnAssets": -0.53169, "returnOnEquity": -1.10868, "freeCashflow": -3998829, "operatingCashflow": -5294048, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Salarius Pharmaceuticals, Inc.", "longName": "Salarius Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1740170028, "exchange": "NCM", "messageBoardId": "finmb_330031056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.48148, "regularMarketPrice": 1.33, "regularMarketChange": -0.01999998, "regularMarketDayRange": "1.31 - 1.37", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2196784, "fiftyTwoWeekLowChange": 0.110000014, "fiftyTwoWeekLowChangePercent": 0.090163946, "fiftyTwoWeekRange": "1.22 - 7.2", "fiftyTwoWeekHighChange": -5.87, "fiftyTwoWeekHighChangePercent": -0.81527776, "fiftyTwoWeekChangePercent": -70.7539, "dividendDate": 1563753600, "earningsTimestampStart": 1742468340, "earningsTimestampEnd": 1742817600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.14, "epsForward": -9.17, "fiftyDayAverageChange": -0.5811, "fiftyDayAverageChangePercent": -0.3040657, "twoHundredDayAverageChange": -0.82342494, "twoHundredDayAverageChangePercent": -0.3823792, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]